RAFAEL HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
RAFAEL HOLDINGS, INC. (RFL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 1.00 million shares for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2025-10-29
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-07-31 was 0.00 shares.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-04-30 was 0.00 shares.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-01-31 was 0.00 shares.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-10-31 was 1.00M shares.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 1.00M shares, a 0.00% change from fiscal 2024.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 1.00M shares.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2021 was 118.41K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2025-07-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | 0.00 shares derived: sum of 2 quarters · filed 2025-10-29 | 0.00 shares derived: sum of 3 quarters · filed 2025-10-29 | 1.00M shares 10-K · filed 2025-10-29 |
| 2025-04-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | 0.00 shares derived: sum of 2 quarters · filed 2025-06-11 | 1.00M shares 10-Q · filed 2025-06-11 | 1.00M shares derived: sum of 4 quarters · filed 2025-06-11 |
| 2025-01-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | 1.00M shares 10-Q · filed 2025-03-14 | 1.00M shares derived: sum of 3 quarters · filed 2025-03-14 | |
| 2024-10-31 | 1.00M shares 10-Q · filed 2024-12-11 | 1.00M shares derived: sum of 2 quarters · filed 2024-12-20 | ||
| 2024-07-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | 1.00M shares 10-K/A · filed 2024-12-20 | ||
| 2024-04-30 | 1.00M shares 10-Q · filed 2024-06-14 | |||
| 2022-04-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | 237.76K shares derived: sum of 2 quarters · filed 2022-06-14 | 518.30K shares 10-Q · filed 2022-06-14 | |
| 2022-01-31 | 237.76K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | 518.30K shares 10-Q · filed 2022-03-17 | ||
| 2021-10-31 | 280.54K shares 10-Q/A · filed 2022-02-28 | |||
| 2021-07-31 | 118.41K shares 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |